Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2009 | Betanodavirus non-structural protein B2 as a necrotic death factor, induces mitochondria-mediated cell death in fish cells | Su, YC; Wu, JL; Hong, JR | Virology 385(1), 143-154 | | | |
2011 | Betanodavirus up-regulates chaperone GRP78 via ER stress: Roles of GRP78 in viral replication and host mitochondria-mediated cell death | Su, YC; Wu, JL; Hong, JR. | Apoptosis 16(3), 272-287 | | | |
2012 | Biochemical characterization of a nevel laccase from the basidiomycete fungus Cerrenna sp. WRI | Chen, SC; Wu, PH; Su, YC; Wen, TN; Wei, YS; Wang, NC; Hsu, CA; Wang, HJ; Shyur, LF | PROTEIN ENGINEERING DESIGN & SELECTION 25, 761-769 | | | |
2012 | Biochemical characterization of a novel laccase from the basidiomycete fungus Cerrena sp. WR1. | Chen, SC; Wu, PH; Su, YC; Wen, TN; Wei, YS; Wang, NC; Hsu, CA; Wang, AHJ; Shyur, LF | Protein engineering design & selection 25(11), 761-769 | | | |
2012 | Biological degradation of anthroquinone and Azo dyes by a novel laccase from Lentinus sp. | Hsu, CA; Wen, TN; Su, YC; Jiang, ZB; Chen, CW; Shyur, LF | ENVIRONMENTAL SCIENCE & TECHNOLOGY 46, 5109-5117 | | | |
2017 | Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy. | Su, YC; Burnouf, PA; Chuang, KH; Chen, BM; Cheng, TL; Roffler, SR | NATURE COMMUNICATIONS 8, 15507 | | | |
2021 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity | Ho, KW; Chen, IU; Cheng, YA; Liao, TY; Liu, ES; Chen, HJ; Lu, YC; Su, YC; Roffler, SR ; Huang, BC; Liu, HJ; Huang, MY; Chen, CY; Cheng, TL | Journal of nanobiotechnology 19, 16 | | | |
2019 | Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer. | Cheng, YA; Chen, IJ; Su, YC; Cheng, KW; Lu, YC; Lin, WW; Hsieh, YC; Kao, CH; Chen, FM; Roffler, SR ; Cheng, TL | Biomaterials science 7(8), 3404-3417 | | | |
2017 | Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors | Chang, IS; Jiang, SS; Yang, JC; Su, WC; Chien, LH; Hsiao, CF; Lee, JH; Chen, CY; Chen, CH; Chang, GC; Wang, Z; Lo, FY; Chen, KY; Wang, WC; Chen, YM; Huang, MS; Tsai, YH; Su, YC; Hsieh, WS; Shih, WC; Shieh, SH; Yang, TY; Lan, Q; Rothman, N; Chen, CJ ; Chanock, SJ; Yang, PC; Hsiung, CA | American journal of respiratory and critical care medicine 195(5), 663-673 | | | |
2022 | Glucuronides: From biological waste to bio-nanomedical applications | Burnouf, PA; Roffler, SR ; Wu, CC; Su, YC | Journal of controlled release : official journal of the Controlled Release Society 349, 765-782 | | | |
2009 | Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems. | Cheng, CM; Chu, PY; Chuang, KH; Roffler, SR; Kao, CH; Tseng, WL; Shiea, J; Chang, WD; Su, YC; Chen, BM; Wang, YM; Cheng, TL | Cancer Gene Therapy 16, 83-90 | | | |
2017 | Low-Level MHC Class II Expression Leads to Suboptimal Th Cell Response, Increased Autoaggression, and Heightened Cytokine Inducibility | Chen, YT; Su, YC; Chang, ML; Tsai, PF; Kung, JT | JOURNAL OF IMMUNOLOGY 198(5), 1928-1943 | | | |
2016 | Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. | Chen, BM; Su, YC; Chang, CJ; Burnouf, PA; Chuang, KH; Chen, CH; Cheng, TL; Chen, YT; Wu, JY; Roffler, SR | Analytical chemistry 88(21), 10661-10666 | | | |
2009 | Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe. | Tzou, SC; Roffler, S; Chuang, KH; Yeh, HP; Kao, CH; Su, YC; Cheng, CM; Tseng, WL; Shiea, J; Harm, IH; Cheng, KW; Chen, BM; Hwang, JJ; Cheng, TL; Wang, HE. | Radiology 252(3), 754-762 | | | |
2014 | PET Imaging of beta-Glucuronidase Activity by an Activity-Based 124I-Trapping Probe for the Personalized Glucuronide Prodrug Targeted Therapy. | Su, YC; Cheng, TC; Leu, YL; Roffler, SR; Wang, JY; Chuang, CH; Kao, CH; Chen, KC; Wang, HE; Cheng, TL | Molecular Cancer Therapeutics 13(12), 2852-2863 | | | |
2020 | Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex | Chen, E; Chen, BM; Su, YC; Chang, YC ; Cheng, TL; Barenholz, Y; Roffler, SR | ACS nano 14(7), 7808-7822 | | | |
2010 | RGNNV induces mitochondria-mediated cell death via newly synthesized protein dependent pathway in fish cells | Wu, HC; Wu, JL; Chu, HL; Su, YC; Hong, JR | Fish & Shellfish Immunology 29(3),451-463 | | | |
2015 | Selective Delivery of PEGylated Compounds to Tumor Cells by anti-PEG Hybrid Antibodies. | Tung, HY; Su, YC; Chen, BM; Burnouf, PA; Huang, WC; Chuang, KH; Yan, YT; Cheng, TL; Roffler, SR | Molecular cancer therapeutics Epub ahead of print | | | |
2010 | Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. | Su, YC; Chen, BM; Chuang, KH; Cheng, TL; Roffler, SR | Bioconjugate chemistry 21(7), 1264-1270 | | | |
2020 | Structural basis of polyethylene glycol recognition by antibody. | Lee, CC; Su, YC; Ko, TP; Lin, LL; Yang, CY; Chang, SS; Roffler, SR ; Wang, AH | Journal of biomedical science 27, 12 | | | |